Cargando…
Hybrid Au@alendronate nanoparticles as dual chemo-photothermal agent for combined cancer treatment
A gold therapeutic nanoplatform with the same molecule used as reductant, coating and therapeutic agent has been developed in a one-pot, one-phase process using alendronate, a drug from the bisphosphonate family known for its antitumor effects. In addition, the core made of gold nanoparticles (NPs)...
Autores principales: | Plan Sangnier, Anouchka, Aufaure, Romain, Motte, Laurence, Wilhelm, Claire, Guenin, Erwann, Lalatonne, Yoann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Beilstein-Institut
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278761/ https://www.ncbi.nlm.nih.gov/pubmed/30546991 http://dx.doi.org/10.3762/bjnano.9.273 |
Ejemplares similares
-
Magnetic Silica-Coated Iron Oxide Nanochains as Photothermal Agents, Disrupting the Extracellular Matrix, and Eradicating Cancer Cells
por: Kolosnjaj-Tabi, Jelena, et al.
Publicado: (2019) -
Zn doped iron oxide nanoparticles with high magnetization and photothermal efficiency for cancer treatment
por: Kasparis, Georgios, et al.
Publicado: (2022) -
Synthesis and activation of an iron oxide immobilized drug-mimicking reporter under conventional and pulsed X-ray irradiation conditions
por: Barosi, Anna, et al.
Publicado: (2020) -
TRAIL acts synergistically with iron oxide nanocluster-mediated magneto- and photothermia
por: Belkahla, Hanene, et al.
Publicado: (2019) -
Biocompatible astaxanthin as a novel marine-oriented agent for dual chemo-photothermal therapy
por: Nguyen, Van Phuc, et al.
Publicado: (2017)